Reduced amounts of hepatic cholesterol were noted in mice treated with fenofibrate alone but not with ASO-Fsp27 alone; there was a trend for further decrease in mice receiving the combined therapy, but it did not reach statistical significance ( Fig. 2D ).
← all excerpts
Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
1
—
—